Innovation Medical(SZ:002173) Sou Hu Cai Jing·2025-11-24 14:32Core Viewpoint - As of November 24, 2025, Innovation Medical (002173) closed at 21.12 yuan, marking a 2.52% increase, with a trading volume of 210,800 hands and a transaction value of 441 million yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, the company's main revenue was 597 million yuan, a year-on-year decrease of 2.11% [3] - The net profit attributable to shareholders was 4.7244 million yuan, a year-on-year increase of 116.97% [3] - The third quarter of 2025 saw a single-quarter main revenue of 196 million yuan, down 3.16% year-on-year, while the single-quarter net profit attributable to shareholders was 16.0857 million yuan, up 236.15% year-on-year [3] - The company reported a debt ratio of 17.84% and investment income of 29.5055 million yuan [3] Group 2: Market Activity - On November 24, 2025, the net inflow of main funds was 42.1095 million yuan, accounting for 9.56% of the total transaction value [1][2] - Over the past five days, the stock experienced fluctuations, with a notable net outflow of main funds on November 21 and November 20, amounting to 43.7524 million yuan and 64.4199 million yuan respectively [2] - The stock's performance in terms of trading volume and turnover indicates active market participation, with a turnover rate of 5.06% on November 24 [1] Group 3: Industry Comparison - Innovation Medical's total market value is 9.32 billion yuan, significantly lower than the industry average of 18.81 billion yuan, ranking 16th out of 42 in the medical services sector [3] - The company's price-to-earnings ratio (P/E) stands at 1479.53, compared to the industry average of 359.81, indicating a relatively high valuation [3] - The gross margin of Innovation Medical is 10.08%, which is considerably lower than the industry average of 35.56%, ranking 40th out of 42 [3]